NEW NIH AND NHLBI POLICIES AND FUNDING OPPORTUNITIES FOR CLINICAL TRIALISTS (8).png
 
 

Career Escalator is a new initiative at the CVCT Forum aimed at the professional development of the young investigators of the CVCT community. Keep an eye for the activities and sessions with the tag 'Career Escalator' and remember to RSVP TODAY as limited space is available. 

 

The 'Career Escalator' program is involving the NIH, NHLBI, the ESC Cardiologist of Tomorrow group and many of the CVCT Faculty. 


 
 
 

 Events & activities

 
NEW NIH AND NHLBI POLICIES AND FUNDING OPPORTUNITIES FOR CLINICAL TRIALISTS (6).png
 
NEW NIH AND NHLBI POLICIES AND FUNDING OPPORTUNITIES FOR CLINICAL TRIALISTS (9).png

Course - Thursday, November 30, 8:00am-10:00am

NEW NIH & NHLBI POLICIES AND FUNDING OPPORTUNITIES FOR CLINICAL TRIALISTS

(all times/speakers tentative)

NIH is the largest public funder of clinical trials in the United States with NHLBI being the primary Institute responsible for heart, lung, blood, and sleep-related research funding. Over the last couple of years, NIH has embarked in a comprehensive reform process with the overall goal of improvingthe quality and efficiency of the clinical trials it supports. NHLBI has been at the forefront of this effort, by developing new specific Funding Opportunity Announcement (FOA) for the different types of clinical trials it supports, from early phases to large multisite trials. The workshop will review the different types of FOAs available to clinical investigators and their specific requirements, with special focus on specific opportunities for new or early stage investigators.

NIH course program.JPG
 

Course - Thursday, November 30, Lunch time

"Career Escalator : how the NIH can help trialists of the future?"

Come and meet Mike Lauer the NIH Deputy Director for Extramural Research - Q&A session

NIH is the largest public funder of clinical trials in the United States with NHLBI being the primary Institute responsible for heart, lung, blood, and sleep-related research funding. Over the last couple of years, NIH has embarked in a comprehensive reform process with the overall goal of improvingthe quality and efficiency of the clinical trials it supports. NHLBI has been at the forefront of this effort, by developing new specific Funding Opportunity Announcement (FOA) for the different types of clinical trials it supports, from early phases to large multisite trials.

Dr. Michael Lauer, the NIH's Deputy Director for Extramural Research, will present an update of the latest NIH initiatives related to clinical trials funding and will engage the audience in a stimulating Q&A session so don't forget to submit your questions. 

*Please note: lunch boxes will be served during this session.

 

 
NEW NIH AND NHLBI POLICIES AND FUNDING OPPORTUNITIES FOR CLINICAL TRIALISTS (10).png

Speed-Networking session - Friday, December 1, Lunch time

*Please note: lunch boxes will be served during this session.

 
NEW NIH AND NHLBI POLICIES AND FUNDING OPPORTUNITIES FOR CLINICAL TRIALISTS (11).png

Speed-Networking session - Saturday, December 2, Lunch time

*Please note: lunch boxes will be served during this session.